XBIO
Xenetic Biosciences, Inc.
NASDAQHealthcareBiotechnologyUS
Rating:C-
Company Profile
CEO
James F. Parslow
IPO Date
2016-06-30
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Xenetic Biosciences, Inc.
CEO
James F. Parslow
IPO Date
2016-06-30
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 2,500 |
| $2.17 |
| 5 Jan 2026 | Dastoor Firdaus J. | director | A-Award | Acquired | 2,500 | $2.17 |
| 5 Jan 2026 | Kornberg Roger D. | director | A-Award | Acquired | 2,500 | $2.17 |
| 5 Jan 2026 | Borisenko Grigory G. | director | A-Award | Acquired | 2,500 | $2.17 |
| 13 Dec 2024 | Borisenko Grigory G. | director | A-Award | Acquired | 2,500 | $4.24 |
| 13 Dec 2024 | Kornberg Roger D. | director | A-Award | Acquired | 2,500 | $4.24 |
| 13 Dec 2024 | Dastoor Firdaus J. | director | A-Award | Acquired | 2,500 | $4.24 |
| 13 Dec 2024 | VINOGRADOV ALEXEY ANDREEVICH | director | A-Award | Acquired | 2,500 | $4.24 |
| 21 Jun 2024 | PARSLOW JAMES F | Interim CEO and CFO | A-Award | Acquired | 20,000 | $3.99 |